-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Reiterates Buy on CG Oncology, Raises Price Target to $100

Benzinga·11/17/2026 14:37:48
Listen to the news
Truist Securities analyst Gregory Renza reiterates CG Oncology (NASDAQ:CGON) with a Buy and raises the price target from $85 to $100.